Post by
kuatolives on May 09, 2017 7:19pm
Bold and Aggressive
Listened to the CC. What a joke. Adams must have used the words"Bold and Aggressive" 100 times. Sounded like a greasy politician.
Best question: "What differentiates your Zontivity selling efforts from Mercks?"
Adams: "The label."
That's your strategy? The effing LABEL?
To zero with a bullet. Might actually see if anyone is selling any PUT options on this pig, I might buy a few. This company is going to drown in its debt this year, which will amount to 1/3rd of its revenue. Also, expect its directors to start dumping shares in the next few months, which will put more downward pricing. The smart ones will try and get some money instead of nothing.
Bold and Aggressive. What a joke.
Comment by
biggerr on May 09, 2017 8:05pm
by "label" he probably meant targeting it for the PAD crowd while Merck was targeting the ACS crowd who already were getting lots of similar drugs and didn't need additional anticoagulants like Zon
Comment by
kuatolives on May 09, 2017 8:57pm
So.... Merck spent all that money bringing zontivity to market, beat their heads against the wall trying to sell scripts etc etc, couldn't do it, tried again, failed again, and nobody thought of that huh?
Comment by
biggerr on May 10, 2017 1:27am
That's what Bloom and Burton or whatever their name is, say in their analysis of ARZ from a few weeks ago, you can check this board, I posted a link to their article